and shots. >> reporter: some americans may choose the pfizer or moderna vaccine over j&j >> i don't mind having to come back for a second dose if it is going to be a little more effective. >> reporter: americans are told in advance which vaccines they are receiving. >> some americans are reluctant to get this vaccine. >> take what you can get and especially when you have a vaccine that's disinfected, we are lucky to have this >> reporter: one more important stat, while the j & j vaccine is 72% in the u.s., the flu vaccine is just 45% or 60% effective >> what's the timeline >> reporter: yeah, they could get emergency authorization within weeks the government already has a $1.5 billion with j&j for 100 million doses by the end of june, lester >> tom, thank you very much. >>> today's development, i spoke a short time ago with dr. anthony fauci to get some perspective. i started off asking him if the new vaccine news was positive or disappointment >> this is actually good news. it is valued and the whole effort of getting more vaccine candidates into the mix. you know we have two succes

j&j says its vaccine is 72 effective at preventing covid in the u.s. 85% effective and preventing the most serious symptoms, that compares to the pfizer and moderna vaccines are 95% effective. importantly the company says it was less effective against the dangerous south african strain >> we have 100% efficacy against going to the hospital, 100% efficacy against death this is a big result >> reporter: the j&j vaccine has two big advantages it requires one shot and not two like the others. it does not need to be kept at ultra cold temperatures, making it easier to ship and distribute it would be a mistake to compare j&j's 72% efficacy rate with a 95% efficacy rate. >> to me, one shot is better than two because i hate needles and shots. >> reporter: some americans may choose the pfizer or moderna vaccine over j&j >> i don't mind having to come back for a second dose if it is going to be a little more effective. >> reporter: americans are told in advance which vaccines they are receiving. >> some americans are reluctant to get this vaccine. >> take what you can get and especially when yo

stofls that the j&j vaccine was tested. we're fighting a different virus today than we were three months ago when previous trials were done shepard, unfortunately we're probably going to be fighting a different virus three months from now so most important in winning this battle is getting as many people vaccinated as possible. now, over the next few weeks, there will be a lot more information coming out about the j&j vaccine as the fda reviews its emergency use authorization application, as a lot of independent experts take a very close look at the data that's going to help people make an informed choice but most important right now, we need to get people vaccinated. we need to prevent those hospitalizations and deaths, and the j&j vaccine looks very effective in doing that. then we need to be vigilant because the virus is going to keep mutating. the faster we get shots in arms, the more people we get vaccinated in this country and around the world, the better we're going to do in containing that further spread and the fur

the electoral vote of tennessee appears to be regular in form and authentic and appears that donald j. trump of florida received 11 votes for president and michael r. pence of the state of indiana received .1 votes for vice president area >> are there any objections to the certificate of the vote of tennessee that has been verified as regular in form and authentic? this certificate from taxes, the parliamentarians advise me is the only certificate of vote from the state and purports to be a return from the state is annexed the certificate of authority of that state and purports to appoint ascertained electors. >> mr. president, the certificate of the electoral vote of the state of texas seems to be regular in form and authentic and appears therefrom that donald j. trump of the state of florida received 38 votes for president and michael r. pence of the state of indiana received 38 votes for vice president. >> are there any objections to counting the certificate of the vote of the state of texas but the teller has verified appears to be regular in form and authentic? certificate, this f

j&j under 150, yeah, but not much more than that. the one that is confounding is lily i am thinking that had quite a run. don't think it's on -- it is definitely on koed covid-19. it's on alzheimer's. >> right. >> on this gamestop, before they lose a lot, i mean, i am calling in from the hospital bed because of gamestop. it's just not right. >> that's exactly -- >> i can't watch people lose all this money. >> yeah, jim - >> sorry. >> it's morgan i'm glad you are feeling better. i wanted to go back to that point talking about taking the home run and it will be a race to the bottom. if history is any indicator it could end badly. i want your thoughts on that, because that's going to be scary. >> i have nurses and doctors here saying should i -- i mean, these are real people here working real hard. first responders ask me about gamestop guys, have some heart. you know, company issue a statement saying we don't know what's going on. we want to raise money we don't have a good balance sheet. the short sellers, who really covered that shor

thing on j&j, one shot. >> yeah. i've spoken to their scientists who really didn't have time to speak to me so i don't want to say that i got the expansive, but it is pretty clear, their level of confidence was high obviously the question is can they do the 95%? i mean, i took the moderna, and i listened to once again to the unbelievable work that meg is doing. felt quite confident the k you imagine if j&j has even 90% in one shot we save lives and do real things particularly if we expand testing and make it so if we find out we're sick, we get the regeneron. i'm starting to feel like you know what? that wall that i'm looking at should have more green, not less because there's a lot of things that would go right in the forth quarter if j&j delivers. david, there is some -- do you remember, david, a year ago when people said it's got to take at least four years because the mumps vaccine took four years and what could have been easier to conquer than mumps? this thing is a growing virus that is far worse than it was. a

thatpears, therefrom, donald j. trump of the state of florida received five votes for president and michael r. pence of the state of indiana received five votes for vice president. >> are there any objections to counting the certificate of the vote in the state of west virginia that the teller has verified appears to be regular in form and authentic? this certificate from wisconsin is the only certificate from that state, purports to be a return from the state, and has annexed to it a certificate of authority from the state purporting to appoint or ascertain electors. president, the certificate of the electoral vote of the state of wisconsin seems to be regular in form and authentic, and it appears therefrom that joseph r biden jr. of the state of delaware received 10 votes for president and kamala d harris of the state of california received 10 votes for vice president. >> for what reason does the gentleman from texas rise? >> mr. president, i object to the electoral votes in the state of wisconsin because 71 house

and i think j & j will do that huge run-up as well, so i would be a buyer of j & j right now right here on this news. remember, pfizer and moderna both pulled back dramatic kri. so get in, ride the pop and leave the stock. >> is there a further pop, you think? is phase three is favorable, do we see another pop here? >> i think it's a catalyst that then highlights also just the other parts of the business, so what steve's saying highlights what guy and pete were saying. their pharma business and it's been guided to be above market growth in policy pursuits, i think are very bullish medical devices business will begin to normalize in 2021 is this a catalyst that unlocks a value for people that are mostly neutral on this flame yes, i think you can stay here and get something out of this. >> we've been having this narrow pharma conversation. of course this has much broader implications for the economy and the opening trade in general if one is to believe it's much easier to disturb -- it's much easer to manufacture under a need one single dose instead of two doses to achieve efficacy, i wou

j&j, if we see good data, that does not mean we will have the vaccine rolled out. we will see j and j submitted for emergency use authorization which is a quicker pathway that is a little more flexible than getting a product to people in an emergency situation like a pandemic. from the fda process that we see play out from pfizer and moderna, there'll be an advisory committee that will review the data. it is very fun to cover, enthralling to listen to and as far as the debate around vaccine and the pros and cons, but coming out of that process, the review process will take about 18 days for the fda for pfizer and mentor now. a little under three weeks from the time that j&j submits to the time they are able to get authorization. we are looking at an authorization potentially coming in late february, probably more likely in the march the putting on how fast. >> next, president-elect joe biden unveiling his distribution plan. after that, house speaker nancy pelosi's briefing on election security and the president elect's economic plan. and then from this morning's "w

i love j & j. the idea is appealing. >> so you think by summer, by the end of summer every american who wants one should be able to get a vaccine and be protected. >>? >> jae, so the messaging was interesting. 100 days, 100 million doses. 100 days mask wearing. people think that the biden administration a little bold. which was interesting, because, you know, instead of sort of like setting way high expectations like everybody get vaccinated by -- in one month, i think setting realistic expectations and then exceeding them has been the strategy. >> okay. you know, getting the doses is one thing. getting the vaccine, right? there is the manufacturing, but also the distributing if you will, and then the actual administering. talk about where we have hiccups or possible delays still in the process. >> yes, so california is amongst the worst in the states in the country currently for the percentage of vaccines allocated to the states that reached the arms of the people living here. and a lot of people

will j&j vaccines' sooner than expected and why are doctors prescribing it if j&j got some good news from the vaccine front, we'll hear from it there. we'll get insights from emerging bio systems. we know they have business with j&j. maybe they're sitting on a billion doses or just waiting on the thumbs up with the fda, who knows? there is the other huge conference next week, ces, the consumer electronics show, interested in a keynote from amd presenting on tuesday morning. microsoft on wednesday morning what do i want to hear i want to hear about their p.c. engagement business. microsoft we want to know about everything you know i like both of them a great deal kb home's report on tuesday. people fleeing the cities for the suburbs because of the pandemic kb home is a big part of california that people are moving to and thenit is back t the jp morgan healthcare, this time to hear pfizer and cvs talk about many things including the vaccine. i would not be surprised if pfizer can roll out more doses than expect it and cvs is ready to administer them from all 10,000 stores as soon as th

let's begin with the j&j breaking news. our senior medical correspondent elizabeth cohen is with us. can you explain what that means for everyone watching? >> the bottom line is, if the johnson & johnson vaccine gets authorization from the fda and you are looking for a vaccine, and you've looked for moderna and pfizer, which are better, there's no question, but you can't find them because there's not enough of them but you can get johnson & johnson, experts are telling me, get it. do not hesitate to get it. it is still a good vaccine. it still gives protection. it's just not quite as good as pfizer and moderna. but it is still good. remember, there are plenty of vaccines out there that have the level that johnson & johnson is giving for other things. the flu shot, for example, sometimes only 50% effective. and johnson & johnson is way better than that. so let's take a look at what johnson & johnson found. when they were looking at the ability of johnson & johnson's vaccine to prevent moderate to severe cases, they found it

guest: j&j, just because we see good data, that doesn't mean the next day it will be rolled out. we will see j&j perhaps in a few days submit for emergency use authorization, quicker pathway that is more flexible for regulators getting a product to people in an emergency situation. from this fda process we see play out with pfizer and moderna , the fda will have an advisory committee, independent experts, review the data in a public meeting that lasts about eight to 10 hours, fund to cover, and drawling to listen to. -- fun to cover, and and throttling to listen to -- enth ralling to listen to. a little under three weeks from the time j&j submits to the time they may be able to get an authorization, that is what i would expect. given that timeline, we are looking at an authorization potentially in late february, probably more likely in march depending on how fast the process can go. host: gino, atlantic city, new jersey. caller: good morning. is there enough infrastructure in place to keep this stuff at its 70 degrees below zero temperature, and is there a range of where it is sa

good story for j&j. if we were talking about j&j, and i remember talking about it with you, scott. we were talking about mesh and open y opioids and talc and the overhang of litigation and the health care company that's a behemoth and now this feel good story on the vaccine and you couple that with josh made a point earlier. you can talk about healthcare. we can argue about inflation until we're blue in the face and there will be an increase in health care spending and devices were down. device spending will not be down this year. it will certainly be up. this is a top ten s&p 500 name that never gets talked about because of the businesses that it's in, but it is a leader in the consumer brand space and it's a leader in devices and a leader in drugs and this is a great place if you're underweight in healthcare, you'll get a nice pop from the vaccine and i think the data will be good and that's what they're indicating and you saw merck back there with the vaccine. this is a great core position innior heal

and j&j, and the stock is down, and 3m and the dow is now down at a session low of 730 points. 2.5%. we are back right after this. >>> all right. welcome back. moments ago the dow was down more than 700 points and pretty much at that mark right now off 695, 2.3%. a lot of broad market contagion either causesed by the reddit rebellion and the margin calls that we talked the about and the market is down 700 and also by the way, the vix is soaring. now we called the vix the quote fear gauge, because it is generally going to mention the option spread, but theday it is not a measure of the spread, but it may be measuring the options market. and today it is up 22%, and seven points on the vix and up big this week, and of course, the huge spreads in some of the options as well, and that is really what the vix is designed to mention and measure and despite we call it the fear gauge, and we don't know if it is fear or volatility, but the vix is up 22%. >>> though robinhood and reddit and gamestop are grabbing the business headlines, maybe they should not be. there is a double dose of good new

cnbc's meg tirrell, and what can you tell us about the j&j vaccine? >> well, the good news, the reassuring news of the clinical trial that experts tell me may bode well for how effective the j and j vaccine is for preventing disease what they looked is levels of neutralizing antibodies, which is important for the ability of blocking the cells a single shot reduced the antibodies similar to what we saw with moderna and pfizer. we don't know if that will translate to similar 90% efficacy in preventing disease but j and j's chief officer dr. paul stoffels told me if antibodies are the driver, we should see a high level of efficacy vaccine scientist, dr. paul offit, we don't know about the immune response that leads to protection against covid that is why he told me, quote, why you do phrase three studies. the results are expected by the end of january, and beyond being just one shot, this vaccine is easier to handle than the mrna vaccines it can be stored at fridge temperatures for three months and long-term at minus 4 degrees fahrenheit, and now the bad

mark mcclellan with us today , the j & j vaccine rolling pretty soon. coming up, next, this is some story a former journalist who ended up falling in love with the guy they called the pharma pro. we actually have an interview with her, stick around, coming up, next. idea for a trade. oh yeah, you going to place it? not until i'm sure. why don't you call td ameritrade for a strategy gut check? what's that? you run it by an expert, you talk about the risk and potential profit and loss. could've used that before i hired my interior decorator. voila! maybe a couple throw pillows would help. get a strategy gut check from our trade desk. ♪♪ there are many names for enthusiast. but there's only one way to become one... by going all in. the new lexus is. with a lower center of gravity, a more responsive suspension, and an aggressive wider stance. this is what we call going all in on the sport sedan. lease the 2021 is 300 for $359 a month for 39 months. experience amazing at your lexus dealer. i had shingles. horrible. a young thing like me? actually anyone

we see in mild to moderate disease the j&j was 72%. further out in time, we see that with after 28 days it's 85% protective against all strains. and there were no cases of severe disease or death after 49 days after vaccination. arthel: dr. tom freeman is the former director at the centers for disease control and prevention, also president and ceo of resolve to save lives and joining us now, thank you for being here, dr. freeden. with potentially three vaccines on the market within weeks, i want to focus on the overall picture. we recently learned of the u.k. variant. the strain from south africa. now the california strain. do you feel 100% confident that we can conquer covid-19? >> well, arthel, the first thing to say is the vaccines are coming along faster than we could have hoped and with better results than we could have hoped. so we've got two stunningly effective mrna vaccines, the pfizer and moderna product. we're still learning more about the j&j product. it's a single dose. if you look at a single dose of the j&j vaccine and c

j expected to ask u.s. regulators in early february to authorize use of the vaccine and is expected to have millions of doses available in short order for quick shipment. back to you. connell: good news and good explanation in turn of the variance they like the way it goes after serious disease. gerri willis with us on j&j the potential new tool in the fight against a pandemic will tell you why one nba team is applying specially trained dogs to welcome their fans back into the arena for the first time in months. plus the fbi search for the capital rioters is going high-tech will explain that. iceland is issuing digital vaccination certificates. qualifying incoming travelers can prove that they received both vaccine shots will no longer have to quarantine. or present a negative test result of the border. the citizens still not allowed to visit. ♪ “could have been me” by the struts hey, mercedes? how can i help you? the 2021 e-class. motortrend's 2021 car of the year. connell: "after the bell" headlines

ththey're j jeggings! whoaoa. reremove ten y years of yw stains with colgagate optic w e renewal. ♪ oh, oh,h, oh, ozempmpic®! ♪ (annououncer) ononce-weekly y ozempic® is helg many peoeople with type 2 d diabetes lilike emiy lower theieir blood susugar. a a majority o of adults who tookok ozempic® reacached an a1c1c under 7 and mainintained it.t. hehere's your r. ohoh! my a1c i is under 7!! (annnnouncer) and you mamay lose weieight. adulults who tooook ozempicc® t on averarage up to 1 12 pound. i lolost almomost 12 poun! ohoh! (announcerer) for r those alsoso with known hearart disease,e, ozempic® los the ririsk of majojor cardrdiovascularar events such as heheart attackck, stroroke, or deaeath. it lowerers the ris. oh! and d i only havave to t take it oncnce a . ohoh! ♪ oh, oh, o oh, ozempicic®! ♪ (a(announcer)) ozempipic® is nonot for peope withth type 1 didiabetes or diabetitic ketoacididosis. do not shahare needleses or pe. don't t reuse neededles. do n not take ozozempic® i if ye a persrsonal o

the concerns of j & j hitting the production deadlines. "the new york times" is reporting that it is two months behind the original production, and j & j is saying that it is too early to get into the supply commitments signed with the governments, and operation warp speed said that there are expected to be fewer than 10 million doses ready by mid-february and larger in march and april, and the health giant has set a production goal of 1 million by the end of the year, and if the single is shot works, that is enough for 1 billion people. >> thank you, meg. >>> google has a message for the advertisers, and that is topping "on the money. the search giant is pausing all political ads and the policy is kept through the inauguration. and the decision follows an assault on the capitol and comes one day after google suspended president trump's youtub apple is spending $1 million to close the racial divide and it includes an education hub for historically black colleges and universities and developer coding academy based in detroit, and venture ca

there are some signs, some positive signs that we are hearing from j&j. what are you hearing? >> right. so j&j published yesterday in the new england journal of medicine data concerning the antibody response to this vaccine. this is the phase 1, phase 2 clinical trials. the pre-clinical trial data that suggests that this vaccine in the doses that are being used in the big clinical trial, which should be available in the next two weeks, produce a very robust amount of neutralizing antibodies. the neutralizing antibodies are what produces the immunity. this vaccine is interesting because j&j is betting really big that they can get this kind of response from a single dose of the vaccine and it's also important to note that this is a more robust vaccine that doesn't require the ultracold supply chain. this vaccine is stable in a refrigerator for three months. it actually may be longer because similar vaccines that j&j produced, they will say this can be refrigerated for three months which makes its distribution around parts of the united states and in fact around parts of the worl

j are promising. why is that so important today when we are -- as we're learning more about this new vaccine? >> well, ultimately the most important thing people care about is whether you are going to bet severely ill if you get coronavirus. if you only get a mild cold, you don't care. you care about whether you're going to get severely ill and many people have succumbed and died from covid-19. so if the johnson & johnson vaccine results prove to be true. that they appear to be 85% effective at preventing severe disease, that is really important. now it does appear that moderna and pfizer are even more effective, nearly 100%. but the fact is that we don't have enough of those vaccines. and if we could get the johnson & johnson vaccine online a lot faster and many millions of people are able to get this one dose vaccine, that makes a big difference. >> there is value added is exactly what dr. fauci said. dr. wen, hold with me. we have some new tape coming in that i want to get to which is president bid

j. it gave the financial support that we could go ahead on behalf of our collaborators and manufacture a product at risk in parallel with the phase-3 clinical trials that are going on so that when, and hopefully when and if these products get approved by the fda, we'll already have a head start in having a significant number of doses ready to make it available. >> so you -- you believe that some of these companies literally made -- made millions of doses just with the idea that, hey, if it works, we got it get it in people's arms >> that was the concept behind operation warp speed. >> right. >> to take any slack out of the system and do things differently in a nontraditional way. take some additional risk. not with, importantly, jim, patient safety or efficacy but to make sure that we had hundreds of millions of doses available to the public as soon as we can. >> well, look, that's our hope i know that a lot of people are very concerned talk about all the time, we've got -- everyone's go

the reddit squeeze corporate news and j&j with vaccine data that dr. fauci calls a spectacular result our road map begins with the retail trading

they are different in their capacity to induce vigorous immune responses but the j sg j data, i think overall are encouraging in that it can prevent you from being hospitalized and from dying. and in a time where this virus is running wild in this country, and we don't have enough mrna vaccine, i think it's a good sign, assuming that it gets uae approval, and we'll see. >> i had a chance to talk to dr. fauci a few days ago. i said what's the bar? what's the number that you want to see for johnson & johnson. i want to play this response because it's pretty revealing. >> can't go much better than 94%, 95%, which is where moderna and pfizer are, but i would like to see the johnson & j product come around near there, just maybe a few off. if you see it 20 less than that, then you have to be a little careful of that. there's going to be some eyebrows raised about which one you'll want to use. >> all right. the first part of that, it's close on severe. it is 20 points down or more on moderate and severe. so you can see the dilemma this poses now because now people are presented with this qu

, j&j and? >> and i own pfizer. >> yeah. >> i look at moderna i think it's a great company, mel. they are doing so much great work right now potentially with these vaccines and the ability to be able to shift and move and pivot in other directions to go after something else, a different strain and so forth. that's phenomenal, but when i look at the entire company of pfizer and the entire company of j&j that's where i think the difference lies for me right now and that's where i would select both of those names rather than moderna. >> we've got a lot more ahead oven money here's what's coming up next >> the trading frenzy we hind gamestop we'll give you the tiktok on how day traders pushed them higher and squeezed out short sellers and will shares of roku stream higher one big wall street firm sees about a 20% real ahead that tdera and more when "fast money" returns >>> welcome back to "fast money. the gamestop short squeeze rebellion continues as the company surged as much as 145% today before r

tom: can we talk about g and j&j -- about ge and j&j? organic revenue growth is what matters, and the revenues are middle to upper single-digit. that is a constructive sign given this pandemic. jonathan: later we will hear from microsoft after the close. lisa: just a couple of things happening before that. at 8:00 a.m., the imf planning to launch an updated world economic growth forecast. the reason i am interested in this is because we are going to potentially see the effects of the vaccines and how effective they were in all of the studies that came out after the first october reading come of the last time we got this projection from the imf. 11:15 am, you may be looking at brian moynihan of bank of america, jes staley of barclays giving speeches. i am watching the european medicine agency's executive director speaking to the european parliament, to members who have been pretty concerned about the failures in the rollout of astrazeneca, under a lot of pressure right now from certain members of the european union saying they don't want

it appears there from that donald j. trump of the state of florida received five votes for president and michael r. pence of the state of indiana received five votes for vice president. vice president pence: are there any objections to counting the certificate of vote from the that the est virginia teller has verified appears to be regular in form and authentic this certificate from wisconsin the parliamentarian's advised me is the only certificate of vote from that state that purpors to be a return from the state, has annexed to it a certificate of authority from the state purporting to appoint or scertain electors. ms. lofgren: the certificate of the electoral vote of the state of wisconsin seems to be regular in form and authentic and appears that joseph r. biden junior of the state of delaware received 10 votes for president and kamala d. harris

j. so we're, you know, looking for, again, kind of coming off this really crazy interesting 2020, right, where it's really kind of hard to measure things at the intersection of like this global pandemic, this economic shut down, and kind of, you know, i like to describe it as tech with it foot on the gas pedal staples like j &j, we expected them to do well. sound like they did, so that's what we're going to continue to just kind of like view we're also looking at can't wait for starbucks later on really like the story of starbucks, and how they were, you know, really kind of strong going into this pandemic with a really strong user interface in terms of their mobile app, strong customer loyalty program, they're able to get so much data from those customer loyalty programs, to really kind of drive their marketing strategy and sales strategy we're looking at things like that, companies that are using technology to really make their business effective >> ticffany, when you look at where the

>> one last point on the j&j vaccine. the rationale in using the viral vector to develop a vaccine was the it will elicit an antibody response and they do seem to elicit the immune response they may do it as well that's another thing we can't fully measure that's hanging out there. it could make the vaccine attractive i'm sorry, i forgot your question the presumption is when you look for a vaccine -- >> it goes to the question of whether you could take the vaccine to be asymptomatic, you wouldn't get any of the symptoms but yet still be able to effectively shed at the same time >> right so this is where most people are right now. most people -- this is all, you know, a hypothesis we haven't demonstrated this yet. when you look at a vaccine 90, 95% effective, you tend to believe some of that efficacy is being driven not only by a reduction in covid disease, signs and symptoms of covid infection, but it's preventing some people from getting infected in the first place. when we looked at the primate studies, the monkeys deve

j & j, it looks like we will have a third entrant, hospitalizations down week on week for the first time since september, and the pope's got the vaccine, dr. ruth, and jim cramer >> well, i was there for the moderna, by the way, it's not like when you get to the tent for the vaccine, i have a choice you actually have to ask, and i kind of said, well, it's the moderna, okay, thank you, it was good to know that the one thing i would point out, carl, it's incredibly easy and if the federal government were running this, i think we would probably be five weeks away from doing it or getting it and i say that because it takes a second, and then you have to wait another five, six minutes, but it's all being done right now, i'd say in a way that just can't scale. i had a 1:00 appointment and there was a 1:15 appointment, the person behind me and i bet they did 80 people in a very nice staten island people. 80, they just got to be ripping through this thing as if it is the military but we are not there still, it was positive and you get a feeling, if you had it, once you have it, remember i've got

it appears to be therefore donald j. trump of the state of florida received six votes for president and michael r. pence of the state of indiana received six votes for vice president. >> are there any objections to counting the certificate of vote for the state of arkansas that the tellers verified appears to be regular, of form and authentic? >> hearing none. >> hearing none. this certificate from california is the only certificate of vote from the state that purports to be returned from the state and an exed to it a certificate from the authority of that state purporting to a point or ascertain electors. >> mr. president, the certificate of electoral vote of the state of california, i would say the great state of california, seems to be regular, in form and authentic. and it appears there from that joseph r. biden, jr. of the state of delaware received 55 votes for president and kamala harris of california received 55 votes for vice president. >> are there any objections to counting the state of california that the tel

let's start with the j&j results. this is the one-shot vaccine they showed variability across region where is they tested it. in the u.s., 72% efficacy with one shot preventing moderate to severe covid-19. that declined to 57% in south africa, giving an overall global efficacy rate of 66% what johnson & johnson is focusing on is preventing severe disease and preventing deaths. they had 85% efficacy globally that includes south africa we talked about a comparisons to previous mrna vaccines >> this study was done at the height of the epidemic cross three continents when a lot of cases were transmitting and a lot of variants were circulating. across that we got 85% protection against severe disease, 100% protection for death, and 100% protection for hospitalization. when you look at the challenge of the pandemic at the moment it is exactly that. what. >> what you are seeing, guys is johnson & johnson trading down there 3.4% novavax soaring today up 65% we also talked with novavax's ceo this morning, stan irk about how th

of administration here in washington and the other is the fact that biden will likely return to the j c e o a. and this this these 2 events have caused a recap calibration of risk calculations for the gulf states and i think this. this does show that there are there is some movement geopolitically. speaking yet the dilemma is structural in a sense in the current context not of the gulf states have the leverage really to get the other to submit to their well while their strategic interests diverged to the extent that there are allegedly be continued tensions along with the this is this is kind of where. confidence building measures were really important and. the agreement that will be signed tomorrow is one big step in that direction however there's still a lot of heavy lifting ringback needing needed to be. done in order to. return back to the priest 2017 relations so if this was the 1st big step what would you say are the next steps what should we be looking out for not only when the g.c.c. meeting gets underway but in the days and weeks to come how do you see this playing a. that's

biden jr of the state of delaware has received 306 votes donald j. trump of the state of florida as received 232 votes through the whole number of electors appointed to vote for vice president of the united states is 538 within that whole 'd number a majority is 270 the votes for vice president of the united states are as follows comedy harris of the state of california has received 306 votes michael r. pence of the state of indiana has received 232 votes the announcement of the state of the vote by the president of the senate shall be deemed a sufficient declaration of the persons elected president and vice president of the united states each for the term beginning on the 20th day of january 2021 and shall be entered together with the list of the votes on the journals of the senate and the house of representatives the chair now recognizes for the purpose of closing prayer the 62nd chaplain of the united states senate chaplain barry c. black. and there you have it the vice president mike pence really declaring the end of the voting sequence now of al

if that single dose from j & j is approved, what would that mean for the rollout how fast could it make an impact >> yeah, so, shep, thanks for having me on obviously, a single dose would help a lot i think one of the questions that's less clear is how much stock of the j & j vaccine do we have there's some reports it's not gone as well, production has not gone as well either way, look, one dose as a vaccine is so much easier to administer, obviously only have to give half as many doses to cover the same number of people. i just think it would be a really good piece of news for this effort. >> the president is promising to vaccinate 300 million people by early fall so at what point can the states start making decisions about opening up businesses and economies? >> yeah, i think that's going to have to be driven by how things are doing with infections. my relatively optimistic view is we don't have to wait until the end of the summer or beginning of the summer. that by late spring if enough people have been vaccinated, you're going to start seeing case numbers really come down a lot. tha

we need to see more about the j&j vaccine. we've only seen the press release. the fda needs to review it, see the details. but i think it's promising early information and i'm hopeful that we'll see it as a very effective vaccine as part of our overall strategy. chris: you were i think it's fair to say pretty critical of the trump administration's handling of this whole pandemic. now that joe biden is in charge, what are you most encouraged by in the way he's handling the whole covid issue and are there some issues, some areas of the way that his new administration is handling this that still give you concern? >> so i think first of all we're only about 10 days into this so it's difficult to say but what i'm seeing in the first 10 days is really encouraging to me. i think we've seen a very substantial and detailed strategy around vaccination that's been released. fema has been giving out money to states for vaccination, for the vaccination program. new rules were passed to allow doctors and nurses to -- who are retired to vaccinate as part of the program. we're

iran comes back into full compliance with its obligations under the j c v.o.a. the united states would do the same thing and then we would use that as a platform to build with our allies and partners what we problem longer and stronger agreement and to deal with a number of other issues that are deeply problematic in the relationship with iran but we are a long ways from that point around it is out of compliance on a number of fronts and it would take some time should it make the decision to do so for it to come back into compliance in time for us then to assess whether it was meeting its obligations so we're not we're not there yet to say the least iran's foreign minister javad zarif has responded to lincoln's remarks his that the u.s. violative iran deal and caused harm to its population through reimposed sanctions zuhdi if that iran has been abiding by the deal and had sought remedial measures and finalists west the country will never forget what he called trump's macsyma failure towards iran. let's bring in our panel in west jerusalem we have mitchell barak

authorities it would constitute a considerable departure from iran's nuclear commitments under the j c p o a with serious normal nuclear nonproliferation implications now let me recall also the importance of avoiding any steps that could undermine the preservation of the nuclear deal and here i would like to recall all the previous statements by all the participants of the j c p a way that they are interested in keeping this deal a life and that the old will be kept alive as long as all the participants believe are on their obligations the israeli prime minister benjamin netanyahu has condemned iran's move you know of years ago little more than a little iran has announced that it will increase the level of uranium enrichment and will develop industrial capabilities to reach your rhenium underground. this is a blatant and absolute violation of its obligations there is no other explanation other than continuing iran's international to produce nuclear weapons and the iranian government believes by announcing enhanced enrichment it might be able to compel the other signatories to the vie

j&j, you can store it the refrigerator. that is really important. emily: we appreciate your detailed analysis about this. you know more about this than just about anyone. think you for sharing your insights with us. we are going to get to more later in the show on how this fared today. i want to hit microsoft earnings out after the bell. and if there were any market reactions to the president's remarks. did you see anything moving as the president was speaking? >> not yet, microsoft in particular getting a good chunk of the action. 17% of sales being driven by cloud computing. microsoft is doing extremely well, a 4% gain in the post market. looking at some of the other sectors as well. advanced micro devices. shares are down even though it beat estimates across the board with an upbeat forecast on its chip demand. texas instruments also a big strong beat, projecting strong industrial and auto demand. nevertheless, you see both of those stocks down in the red. we will look ahead to tomorrow's earnings. apple and tesla both reporting. you can see in l

it's as much as two months behind its original production schedule j&j t j&j telling us it's premature to get into the specifics of the supply operation warp speed saying yesterday they're expecting fewer than 10 million doses by february the production goal has been 1 billion doses by the end of this year if the single shot works, that's enough for a billion people, shep >> meg, thanks >>> google has a message for its advertisers, and that's what's topping cnbc's "on the money." the search giant pausing all political ads. the policy being kept in place through the inauguration the decision follows an assault on the capitol and comes one day after google sus sppded president trump's youtube account. apple spending $100 million to help close the racial divide it includes three main parts, an education hub for historically black colleges and universities, a developer coding academy based in die troit and venture capitol funding for entrepreneurs. tim cook said we are all accountable to the urgent work of building a more just, more equitable world. and a new survey shows just how inequita

and it appears, therefrom, that donald j. trump of the state of florida received six votes for president. and michael r. pence of the state of indiana received six votes for vice president. >> are there any objections to counting the certificate of vote from the state of minnesota that the teller has verified appeared to be regular, in form, and authentic? hearing none. this certificate from missouri, the parliamentarians advise, is the only certificate of vote from the state that purports to be a return from the state. and that has annex to it, certificate of the authority of the state purporting to appoint or ascertain electors. >> mr. president, the certificate of the electoral vote of the state of missouri seems to be regular, in form, and authentic. and it appears, therefrom, that donald j. trump of the state of florida received ten votes for president. and michael r. pence of the state of indiana received ten votes for vice president. >> are there any objections to counting the certificate of the vote of the state of mi

state of mississippi seems to be regular in form and authentic and it appears there from the donald j. trop of the state of florida received 6 votes for president and michael r. parents of the state of indiana received 6 votes for vice president are there any objections to counting the certificate of vote in the state of mississippi that feller's verified appears to be regular in form and authentic hearing none. this certificate from missouri the parliamentarians advise is the only certificate of vote from the state to purport to be a return from the state that is an extended a certificate from an authority of the state purporting to appoint or ascertain electors mr president the certificate of the electoral vote of the state of missouri seems to be regular in form and authentic and it appears there from that donald j. trump of the state of florida received 10 votes for president and michael r. pants of the state of indiana received 10 votes for vice president. are there any objections to counting the certificate of the vote of the state of missouri that the tellers verified appears to